Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

476 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma.
de Gouw HW, Hendriks J, Woltman AM, Twiss IM, Sterk PJ. de Gouw HW, et al. Among authors: sterk pj. Am J Respir Crit Care Med. 1998 Jul;158(1):315-9. doi: 10.1164/ajrccm.158.1.9703005. Am J Respir Crit Care Med. 1998. PMID: 9655746 Clinical Trial.
Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses.
Friedman BS, Bel EH, Buntinx A, Tanaka W, Han YH, Shingo S, Spector R, Sterk P. Friedman BS, et al. Among authors: sterk p. Am Rev Respir Dis. 1993 Apr;147(4):839-44. doi: 10.1164/ajrccm/147.4.839. Am Rev Respir Dis. 1993. PMID: 8385430 Clinical Trial.
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
Fens N, de Nijs SB, Peters S, Dekker T, Knobel HH, Vink TJ, Willard NP, Zwinderman AH, Krouwels FH, Janssen HG, Lutter R, Sterk PJ. Fens N, et al. Among authors: sterk pj. Eur Respir J. 2011 Dec;38(6):1301-9. doi: 10.1183/09031936.00032911. Epub 2011 Jun 23. Eur Respir J. 2011. PMID: 21700610
Noninvasive methods to measure airway inflammation: future considerations.
Magnussen H, Holz O, Sterk PJ, Hargreave FE. Magnussen H, et al. Among authors: sterk pj. Eur Respir J. 2000 Dec;16(6):1175-9. doi: 10.1034/j.1399-3003.2000.16f25.x. Eur Respir J. 2000. PMID: 11292124 Review.
Asthma severity and susceptibility to air pollution.
Hiltermann TJ, Stolk J, van der Zee SC, Brunekreef B, de Bruijne CR, Fischer PH, Ameling CB, Sterk PJ, Hiemstra PS, van Bree L. Hiltermann TJ, et al. Among authors: sterk pj. Eur Respir J. 1998 Mar;11(3):686-93. Eur Respir J. 1998. PMID: 9596122
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma.
van Veen IH, Ten Brinke A, Sterk PJ, Sont JK, Gauw SA, Rabe KF, Bel EH. van Veen IH, et al. Among authors: sterk pj. Eur Respir J. 2008 Aug;32(2):344-9. doi: 10.1183/09031936.00135907. Epub 2008 May 28. Eur Respir J. 2008. PMID: 18508818
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial.
Nuijsink M, Hop WC, Sterk PJ, Duiverman EJ, de Jongste JC. Nuijsink M, et al. Among authors: sterk pj. Eur Respir J. 2007 Sep;30(3):457-66. doi: 10.1183/09031936.00111806. Epub 2007 May 30. Eur Respir J. 2007. PMID: 17537770 Clinical Trial.
Risk factors of frequent exacerbations in difficult-to-treat asthma.
ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH, Rabe KF, Bel EH. ten Brinke A, et al. Among authors: sterk pj. Eur Respir J. 2005 Nov;26(5):812-8. doi: 10.1183/09031936.05.00037905. Eur Respir J. 2005. PMID: 16264041 Clinical Trial.
Murine models of asthma.
Kips JC, Anderson GP, Fredberg JJ, Herz U, Inman MD, Jordana M, Kemeny DM, Lötvall J, Pauwels RA, Plopper CG, Schmidt D, Sterk PJ, Van Oosterhout AJ, Vargaftig BB, Chung KF. Kips JC, et al. Among authors: sterk pj. Eur Respir J. 2003 Aug;22(2):374-82. doi: 10.1183/09031936.03.00026403. Eur Respir J. 2003. PMID: 12952276 Review.
Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma.
Grootendorst DC, Sterk PJ, Heijerman HG. Grootendorst DC, et al. Among authors: sterk pj. Eur Respir J. 2001 Mar;17(3):374-9. doi: 10.1183/09031936.01.17303740. Eur Respir J. 2001. PMID: 11405514 Clinical Trial.
476 results
Jump to page